An interventional study of physical activity in Hypertension, Dyslipidemia and Diabetes, sponsored by National Institute of Health and Nutrition. Status unknown at 1 site in Japan. Open to participants aged 30 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-03-29.
Sponsored by National Institute of Health and Nutrition · Not applicable, Interventional, and Prevention
The purpose of the present study was to clarify the effects of increase in physical activity on incidence and surrogate marker of cardiovascular diseases. The working hypothesis of the present study was that the physical activity to satisfy the Japanese guideline of Ministry of Health, Labour and Welfare is effective for the primary prevention of the lifestyle-related disease.
6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.
This study's enrollment of 1,085 is above the median of 100 across 4,575 interventional studies indexed under Hypertension.
Browse Hypertension studies →National Institute of Health and Nutrition is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Physically inactive participants receiving both physical activity and dietary counseling
Behavioral: physical activity
Physically active participants receiving only dietary counseling
Physically inactive participants receiving only dietary counseling
The targets of amount of physical activity are 3.3METs•h/day (MVPA) and 10,000 step counts/day.
Objectively measured amount of physical activity
Time frame: 10 years
Surrogate measurement of lifestyle-related diseases (blood pressure, FPG, cho, etc)
Time frame: 5 years
Incidence of lifestyle-related diseases (hypertension, dyslipidemia, diabetes)
Time frame: 10 years
Incidence of musculoskeletal and joint pain
Time frame: 1 year
Ran from Apr 2006 to primary completion in Apr 2014, 96 months.
Of 1,403 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 96 months is above that.
Counting every sponsor, half of 1,498 studies reached it within 23 months; a quarter within 10 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institute of Health and Nutrition